{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T15:07:01Z","timestamp":1793200021546,"version":"4.5.0"},"reference-count":110,"publisher":"Baishideng Publishing Group Inc.","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2020,6,21]]},"DOI":"10.3748\/wjg.v26.i23.3126","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T00:48:03Z","timestamp":1592614083000},"page":"3126-3144","source":"Crossref","is-referenced-by-count":45,"title":["Review of primary sclerosing cholangitis with increased IgG4 levels"],"prefix":"10.3748","volume":"26","author":[{"given":"Charis D","family":"Manganis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger W","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L","family":"Culver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.02.016"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.11.046"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12894"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.22938"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.41841.x"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldv019"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23294"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04658.x"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Erkelens GW, Vleggaar FP, Lesterhuis W, van Buuren HR, van der Werf SD. Sclerosing pancreato-cholangitis responsive to steroid therapy. Lancet 1999; 354: 43-44","DOI":"10.1016\/S0140-6736(99)00603-0"},{"key":"ref10","unstructured":"Ichimura T, Kondo S, Ambo Y, Hirano S, Ohmi M, Okushiba S, Morikawa T, Shimizu M, Katoh H. Primary sclerosing cholangitis associated with autoimmune pancreatitis. Hepatogastroenterology 2002; 49: 1221-1224"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Kawaguchi K, Koike M, Tsuruta K, Okamoto A, Tabata I, Fujita N. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 1991; 22: 387-395","DOI":"10.1016\/0046-8177(91)90087-6"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/BF02788570"},{"key":"ref13","unstructured":"Nakazawa T, Ohara H, Yamada T, Ando H, Sano H, Kajino S, Hashimoto T, Nakamura S, Ando T, Nomura T, Joh T, Itoh M. Atypical primary sclerosing cholangitis cases associated with unusual pancreatitis. Hepatogastroenterology 2001; 48: 625-630"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Kojima E, Kimura K, Noda Y, Kobayashi G, Itoh K, Fujita N. Autoimmune pancreatitis and multiple bile duct strictures treated effectively with steroid. J Gastroenterol 2003; 38: 603-607","DOI":"10.1007\/s00535-002-1108-1"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00772.x"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Zhang L, Lewis JT, Abraham SC, Smyrk TC, Leung S, Chari ST, Poterucha JJ, Rosen CB, Lohse CM, Katzmann JA, Wu TT. IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis. Am J Surg Pathol 2010; 34: 88-94","DOI":"10.1097\/PAS.0b013e3181c6c09a"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0b013e3181c9dac6"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.375"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Culver EL, Williamson KD, Halliday J, Bateman AC, Sadler R, Barnes E, Chapman RW. Elevated serum and tissue IgG4 in PSC are associated with a worse clinical outcome. Hepatology 2012; 56: 1131A-1131A","DOI":"10.1016\/S0168-8278(12)60954-4"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5402\/2012\/325743"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.04.006"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2014.06.010"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2016.16344"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.432"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30237"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2011.03763.x"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/iep.12076"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-009-0130-y"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.04.009"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.161"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.05.019"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2018.018"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.02.007"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.40"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26977"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Tabibian JH, Enders F, Imam MH, Kolar G, Lindor KD, Talwalkar JA. Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis. Ann Hepatol 2014; 13: 384-389","DOI":"10.1016\/S1665-2681(19)30869-5"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.09.015"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Neeman A, Kadish U. Marked eosinophilia in a patient with primary sclerosing cholangitis. Am J Med 1987; 83: 378-379","DOI":"10.1016\/0002-9343(87)90734-0"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Watanabe H, Ohira H, Kuroda M, Takagi T, Ishikawa H, Nishimaki T, Kasukawa R, Takahashi K. Primary sclerosing cholangitis with marked eosinophilic infiltration in the liver. J Gastroenterol 1995; 30: 524-528","DOI":"10.1007\/BF02347572"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Ichikawa N, Taniguchi A, Akama H, Ishiguro H, Kurihara T, Terai C, Hara M, Kashiwazaki S. Sclerosing cholangitis associated with hypereosinophilic syndrome. Intern Med 1997; 36: 561-564","DOI":"10.2169\/internalmedicine.36.561"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2018.08.011"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.72"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Desmet VJ. Histopathology of chronic cholestasis and adult ductopenic syndrome. Clin Liver Dis 1998; 2: 249-264, viii","DOI":"10.1016\/S1089-3261(05)70006-4"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.12.009"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-016-1246-5"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.04.010"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.223"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00872.x"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-006-1908-9"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01103.x"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21219"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Nakazawa T, Ohara H, Sano H, Aoki S, Kobayashi S, Okamoto T, Imai H, Nomura T, Joh T, Itoh M. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc 2004; 60: 937-944","DOI":"10.1016\/S0016-5107(04)02229-1"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112877"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25977"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2616"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.03.031"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1038\/ng.728"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.01.041"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Kawa S, Ota M, Yoshizawa K, Horiuchi A, Hamano H, Ochi Y, Nakayama K, Tokutake Y, Katsuyama Y, Saito S, Hasebe O, Kiyosawa K. HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology 2002; 122: 1264-1269","DOI":"10.1053\/gast.2002.33022"},{"key":"ref60"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1177\/0284185113481018"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/S1873-9946(13)60250-0"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2005.10.007"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.05.017"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Culver EL, Barnes E. IgG4-related sclerosing cholangitis. Clin Liver Dis (Hoboken) 2017; 10: 9-16","DOI":"10.1002\/cld.642"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPT00NHQHXAHDS"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206605"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2008.12.031"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2012.03.001"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.5946\/ce.2014.47.6.555"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1256872"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317993"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1172\/JCI65579"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-016-1853-2"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199703063361003"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.08.017"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02323.x"},{"key":"ref78","doi-asserted-by":"crossref","unstructured":"Boberg KM, Egeland T, Schrumpf E. Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients. Scand J Gastroenterol 2003; 38: 991-995","DOI":"10.1080\/00365520310005172"},{"key":"ref79","unstructured":"Lindor KD, Wiesner RH, Colwell LJ, Steiner B, Beaver S, LaRusso NF. The combination of prednisone and colchicine in patients with primary sclerosing cholangitis. Am J Gastroenterol 1991; 86: 57-61"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"Parkes M, Booth JC, Pillai G, Mee AS. Do steroids help jaundice caused by primary sclerosing cholangitis? J Clin Gastroenterol 2001; 33: 319-322","DOI":"10.1097\/00004836-200110000-00013"},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"Schramm C, Schirmacher P, Helmreich-Becker I, Gerken G, zum B\u00fcschenfelde KH, Lohse AW. Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis. A case series. Ann Intern Med 1999; 131: 943-946","DOI":"10.7326\/0003-4819-131-12-199912210-00006"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02267.x"},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"el-Shabrawi M, Wilkinson ML, Portmann B, Mieli-Vergani G, Chong SK, Williams R, Mowat AP. Primary sclerosing cholangitis in childhood. Gastroenterology 1987; 92: 1226-1235","DOI":"10.1016\/S0016-5085(87)91082-1"},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"Culver EL, Rodriguez A, Bateman A, Collier J, Chapman RW, Barnes E. IgG4-plasma cell infiltrate in the liver and colon of children with PSC. J Hepatol 2012; 56: S543","DOI":"10.1016\/S0168-8278(12)61394-4"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, Fleming TR, Fisher LD, Beaver SJ, LaRusso NF. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989; 10: 430-436","DOI":"10.1002\/hep.1840100406"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2007.01441.x"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"Knox TA, Kaplan MM. A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis. Gastroenterology 1994; 106: 494-499","DOI":"10.1016\/0016-5085(94)90610-6"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.40484.x"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.22131"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.07.004"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2004.09.003"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3181662426"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14829"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000596"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000760"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1007\/s11901-019-00456-2"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28256"},{"key":"ref98","doi-asserted-by":"crossref","unstructured":"Broom\u00e9 U, Olsson R, L\u00f6\u00f6f L, Bodemar G, Hultcrantz R, Danielsson A, Prytz H, Sandberg-Gertz\u00e9n H, Wallerstedt S, Lindberg G. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996; 38: 610-615","DOI":"10.1136\/gut.38.4.610"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26565"},{"key":"ref100","doi-asserted-by":"crossref","unstructured":"Farrant JM, Hayllar KM, Wilkinson ML, Karani J, Portmann BC, Westaby D, Williams R. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991; 100: 1710-1717","DOI":"10.1016\/0016-5085(91)90673-9"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.10.013"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28128"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(19)30006-2"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000020"},{"key":"ref105","doi-asserted-by":"crossref","unstructured":"Cargill T, Barnes E, Culver EL. Expansion of a Novel Subset of PD1+CXCR5-CD4+ T Peripheral Helper Cells in IgG4-Related Disease. Clin Transl Gastroenterol 2020; 11: e00111","DOI":"10.14309\/ctg.0000000000000111"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14512"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-011-0508-6"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26999"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206405"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.06.016"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/1007-9327\/full\/v26\/i23\/3126.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T00:48:12Z","timestamp":1592614092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/1007-9327\/full\/v26\/i23\/3126.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,21]]},"references-count":110,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2020,6,21]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v26.i23.3126","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,21]]}}}